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Abstract Smartphone applications (“apps”) have become
ubiquitous with the advent of smartphones and tablets in
recent years. Increasingly the utility of these apps is being
explored in healthcare delivery. Hydrocephalus is a condi-
tion that is usually followed by a neurosurgeon for the pa-
tient’s life. We explore patient acceptability of a mobile app
as an adjunct to outpatient follow-up of patients with hy-
drocephalus. A questionnaire was circulated amongst pa-
tients with hydrocephalus (adults and children). Patients
were asked questions about their hydrocephalus; expecta-
tions for outpatient follow up, whether they have smart-
phone/tablet/internet access and whether they would be in-
terested in a mobile app for their long term hydrocephalus
follow up. 191 patients completed questionnaires, 154 of
these were completed online and 37 in paper form. 98 re-
spondents were adults (mean age 46) and 93 were children
less than 18 years old (mean age 8). Overall 36.1% of pa-
tients did not know the cause of their hydrocephalus. 96.7%
have a shunt. 76.5% of adults and 80.6% of children had
1-4 shunt surgeries, 14.3% of adults and 11.8% of children
had 5-9 shunt surgeries, 3.1% of adults and 5.4% of chil-
dren had 10-14 shunt surgeries. 71.7% of patients expect to
be followed-up routinely in clinic for life. All children had
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smartphones or tablets, compared to 86.7% of adults. Chil-
dren were more interested in a hydrocephalus app, 84.9%
saying yes, compared to 71.4% of adults. Adults who were
not interested in the app did not have a smartphone or tablet.
Hydrocephalus management is a lifelong task and innova-
tions in technology for engaging patients in its management
are vital. The majority of patients are interested in mobile
apps for outpatient management of hydrocephalus. We will
follow this up with a feasibility study of a custom designed
hydrocephalus app.
Keywords Hydrocephalus · Follow up · Intelligent
approach · Smartphone apps
1 Introduction
Hydrocephalus is variably described as an enlargement of
ventricular system of the brain resulting from inadequate
passage of cerebrospinal fluid (CSF) from where it is pro-
duced within the cerebral ventricles to its point of absorp-
tion into the systemic circulation [1], the incidence in high-
income countries is approximately 79 per 100,000 births
[2]. Treatment of hydrocephalus depends on the aetiology,
with ventriculoperitoneal shunt (VPS) being the common-
est intervention (up to 3500 performed per year in the
UK alone [3]). Endoscopic third Ventriculostomy [4] and
choroid plexus coagulation [5] are less frequently used treat-
ments. Hydrocephalus is generally considered as a condition
that requires lifelong management. In long-term follow-up
series of adults with paediatric-onset hydrocephalus, up to
89% of patients still possess an implanted shunt [5]. It is
commonly advised that adults with hydrocephalus who re-
main shunt dependent should be regularly followed to help
manage and avoid potential complications associated with
chronic shunting [5].
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Headaches are a common complaint amongst patients
with a diagnosis of hydrocephalus even when adequately
treated, with 10-20% of children reporting severe headache
[6]. Serious chronic headaches are seen in approximately
40% of adults with shunted hydrocephalus [7]. Finding new
ways to engage patients with their healthcare is essential.
Mobile healthcare (“m health”) applications (“apps”) are
software programs that run on internet enabled devices like
smartphones. Their potential for use in wide range of med-
ical and health related issues is increasingly being explored
[8]. The “Hydroapp”, developed with John Moores Uni-
versity in Liverpool is a web-based management, adminis-
tration, communication and m-health application that pro-
vides follow-up treatment for patients with hydrocephalus
or chronic headache. Patients will record all the pain events
and the episodes related to those events, as well as a quick
way to fill-in diaries, outcome measures and health ques-
tionnaires.
2 Methods
A questionnaire was circulated in an electronic form via a
google forms through the patient group Shine1 (Spina bi-
fida • Hydrocephalus • Information • Networking • Equal-
ity) and in a paper form in neurosurgical outpatient depart-
ment in the Walton Centre, Liverpool. Parents were asked
to complete questionnaires on behalf of children with hy-
drocephalus. The questionnaire included 33 questions in 2
parts; Part 1 asked participants about their hydrocephalus,
aetiology, number of shunt operations, outpatient follow-up
experience, and accessing emergency or urgent help. Part 2
explored participant access to internet/smartphone technol-
ogy, opinions about using technology to manage living with
your shunt and how important or relevant certain potential
features of a hydrocephalus app would be to them.
3 Results
191 patients completed questionnaires, 154 of these were
completed online and 37 in paper form. As shown in table
1, about 80% of these were completed online and the rest
in paper form. 51.3% of respondents were adults (mean age
46.1, range 18-83 years) and 48.7% were children less than
18 years old (mean age 8, range 0-17 years).
3.1 Aetiology of hydrocephalus
Overall 36.1% of patients did not know the cause of their
hydrocephalus. Of the 98 adults, 29 had normal pressure
hydrocephalus (NPH), 29 did not know the aetiology of
1 https://www.shinecharity.org.uk/
Table 1 Participants in this study
Data collection method Adult Children Total
Online 83 71 154
Paper 15 22 37
Total 98 93 191
their hydrocephalus, 18 had tumour related hydrocephalus,
7 had Idiopathic Intracranial Hypertension(IIH), 7 had post
haemorrhagic hydrocephalus, 5 had post infection hydro-
cephalus and 3 had spina bifida associated hydrocephalus.
Within the paediatric group, 40 of the 93 respondents did not
know the cause of their hydrocephalus. 22 had post haemor-
rhagic hydrocephalus, 9 had NPH, 8 had post infection hy-
drocephalus, 8 had spina bifida associated hydrocephalus,
and 5 had tumour related hydrocephalus. No child had IIH,
compared to 7.1% of adults.
3.2 Shunts
Overall 97% have a shunt, 95.9% of adults and 97.8% of
children currently have a shunt. 76.5% of adults and 80.6%
of children had 1-4 shunt surgeries, 14.3% of adults and
11.8% of children had 5-9 shunt surgeries, 3.1% of adults
and 5.4% of children had 10-14 shunt surgeries. Non of chil-
dren had more than 15 surgeries, compared to 3.1% of adults
who had 15-19 surgeries.
3.3 Waiting time
About 42% of all patients had to wait between 16 and 30
minutes to be seen by specialists, while 5.7% of all patients
had to wait up to 60 minutes. About half of the patients spent
10-15 minutes with doctor or nurse in the clinic. 36.7% of
adults and 25.8% of children spent more than 15 minutes in
clinic.
Fig. 1 Waiting time at the clinic
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3.4 Patients’ expectations for follow up
Patient preference for how they would like to be followed up
can be seen in figure 2. The majority of patients, both adult
and children, would like to be seen by the neurosurgery team
in clinic every 6 months or yearly. 20% of adults prefer to be
seen in clinic only when they have problems. Overall, 71%
of patients were expected to be followed-up routinely in
clinic for life. The commonest long-term concern for these
patients is blockage/shunt failure/malfunction (66/98 adults,
72/93 children) followed by infection (13/98 adults, 16/93
children).
Fig. 2 Patients’ expectations for follow up
3.5 Access to internet/smartphone
The majority of patients have a home computer with inter-
net access (95% of adults and 90% of children). All chil-
dren had smartphones or tablets, compared to 87% of adults.
Type of smartphone was evenly split between Android and
Apple iPhone. 44.9% of adults and 43% of children owning
Android smartphone versus 40.8% of adults and 53.8% of
children owning an Apple iPhone.
Fig. 3 Type of smartphone
3.6 Interest in a hydrocephalus app
Children were more interested in a hydrocephalus app,
84.9% saying yes, compared to 71.4% of adults. Adults who
were not interested in using hydrocephalus app (mean age
56.5 years) didn’t have a smartphone or tablet as shown in
figure 3.
Fig. 4 Patients’ interest in using technology for follow up
Of those who were interesting in using Hydroapp for
long-term follow up, most cited multiple reasons shown in
table 2 as very or extremely important on a scale of 1 to 5
(i.e. from least important to most important). Recording de-
tails about their shunt was the most commonly cited reason
for interest in an app for adults (78% of adult respondents,
though 96% of children also), whilst in children it was to
alert the treating team in 95%. It is obvious that recording
headache score, general health, and alerting medical team,
were also seen by patients as important aspects in term of
using Hydroapp for self-management and follow-up. How-
ever, making video-call in general was the lesser important
aspect from patients point of view.
Table 2 Important aspects of using Hydroapp for follow-up
Adult Children
Record headache score 70% 77%
Record general health and well-being 68% 84%
Alert treating team 86% 95%
Record/update details of your shunt 78% 96%
Video-call appointment 56% 52%
Emergency consultation using video-call 65% 68%
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4 Discussion
According to the Office for National Statistics the percent-
age of adult internet users has increased from 80% in 2011,
when comparable records began, to 89% 2017. Virtually all
adults aged 16 to 34 years were recent internet users accord-
ing to the Office for National Statistics 2. In 2017, 76% of
UK consumers owned a smartphone, up 5% year on year.
Laptops were the second most commonly-owned internet
enabled device in households (64%), followed by tablets
(58%) [9]. Mobile apps are increasingly being used for more
than just social networking and entertainment with 80% of
users aged 18-24 using at least one finance app and almost
two-thirds of users aged 18-24 using a fitness app [9].
There has been an explosion of mobile healthcare ap-
plications in tandem with the expansion of internet access
and smartphone ownership. 325,000 health apps (health, fit-
ness and medical apps) were available on all major app
stores as of 2017. $5.4 billion have been invested in digi-
tal health in 2016 alone [10]. Text message interventions via
mobile phone are widely reported in conditions like in dia-
betes [11]-[15] and in smoking cessation programmes [16]-
[21]. Smartphone apps have been used to allow physicians
to monitor patients with chronic heart failure [22] and in di-
abetes education [23]. Like with diabetes, the application of
“m health” is a promising adjunct to clinical care as it ad-
dresses the demand for ongoing support in the management
of chronic conditions.
There is an obvious enthusiasm for developing m health
apps but there are challenges to adopting this technology. A
study in 2015 showed two-thirds of apps within the NHS
health apps library [24], a pilot programme which list NHS
approved healthcare related mobile apps, sent identifying in-
formation over the internet and did not use encryption. De-
veloping an app that will transmit patient identifiable infor-
mation requires adherence to the major governing legislation
(in the UK this is the Data Protection Act 1998 [25]) and as
such needs to be developed with due diligence.
The Hydroapp is being developed with John Moores
University in Liverpool, in accordance with the require-
ments of hydrocephalus specialists at Alder Hey Children’s
NHS foundation trust and Walton centre, Liverpool. The
central database and server application will be hosted on
AIMES3 data centre, which meets the NHS criteria for infor-
mation security and governance and currently hosting data
for The Institute of Child Health and Liverpool Heart and
Chest Hospital. The central database of Hydroapp will store
anonymised data. Patient profiles will have no name or per-
sonal details that may expose their identity. Collected data
from patients’ smartphones will be saved in numeric format
rather than plain text. The numeric representation of data
2 https://www.ons.gov.uk/
3 http://www.aimes.uk/
will not provide any details about patients, only the server
app can display this representation into understandable for-
mat. Moreover, numeric representation requires much less
storage space and query time.
Hydroapp includes a range of patients self-reported out-
come measure and monitoring forms such as hydrocephalus
outcome questioner (Hydro-OQ), EQ5D-Y and EQ5D-3L,
headache impact test (HIT6), headache diary and visiting
reports. Using Hydroapp as a follow-up technique and data
collection method will ensure that economic and patient-
reported outcomes are recorded efficiently. It will be as-
sumed that the standard use of such smartphone based PRO
(patient reported outcome) and intelligent software will be
able to reduce unnecessary visits to neuroscience centres,
whilst enabling and improving communication between pa-
tient and neurosurgical care and follow by creating appropri-
ate clinical thresholds for alerting medical staff of changes
in symptoms or of changes of behaviours and of symptoms
automatically. Thus, it is improving safety whilst reducing
unnecessary costs and speeding up communications and ac-
cess when it counts.
Hydroapp improves monitoring of historical responses
to therapies and recording of side effects. This platform pro-
vides an on-the-go analysis of a patient’s data, which im-
proves doctor’s productivity and decision-making. The ac-
cumulation of data and doctors’ experience will be stored
in a knowledge base, which enables Hydroapp to train it-
self allowing knowledge to be expressed and bounded to
identifying risk and alert healthcare provider. The use of in-
telligent methods within Hydroapp can improve healthcare
delivery by allowing a proactive resolution such as identify-
ing risk level of certain cases, and then automatically priori-
tise alerts and waiting list. Without such intelligent solution,
too many hours can be spent analysing pain events to re-
veal meaningful patterns, whereas identifying risk in early
stage helps specialists to take action before serious com-
plication occurs. Hydroapp with support of artificial intel-
ligence can absorb thousands of patients’ records and make
sense of them instantaneously. Hydroapp automates all the
heavy lifting of analysis and discovery that take teams of
medical experts hours or days, artificial intelligence does on
the fly to proactively identify problems and pinpoint the un-
derlying root cause. Such application enabled by data sci-
ence and advanced intelligent methods would convey revo-
lutionary impacts in the healthcare domain.
The market penetration of internet access and smart-
phone usage means that the vast majority of our patients
have the potential to engage with smartphone apps in their
daily lives. Our survey shows that there is an appetite
amongst our patients to engage with healthcare in new ways
and with new technologies. We are facing an increasing need
to balance patient expectations with the resources available
in a modern NHS. We have shown that patients expect to be
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followed by their neurosurgery team for life when they have
a shunt. Patients are understandably concerned about the po-
tential for shunt malfunction/infection and wish to maintain
contact with the treating team. These concerns are mirrored
by neurosurgeons who fear missing a potential shunt mal-
function which is potentially a life-changing/life-threatening
event.
The reality is that the vast majority of routine outpa-
tient appointments for hydrocephalus do not uncover new
symptoms that require neurosurgical attention. The patient
+/- their family take time out of school/work and travel, of-
ten significant distances, to attend clinic. Outpatient clinics
are very regularly at capacity or overbooked and the time
and resources spent on these routine interactions could well
be better utilised. When a problem with a shunt does arise,
patients commonly present to their GPs or their local hos-
pital, which can lead to delays in accessing neurosurgical
advice and care. We propose that following these patients
with a hydrocephalus app could facilitate a more efficient
patient-healthcare interaction with proactively responds to
changing symptoms. Thus a technology such as this should
be a perfect vehicle to maintain surveillance of a potentially
catastrophic event like shunt malfunction without overbur-
dening a health service with regular face to face contacts in
the outpatients.
5 Conclusion
Hydrocephalus essentially constitutes a lifelong disease
with brief episodes where patients need actual neurosurgical
input. Innovations in technology for engaging patients in its
management are vital. In this study, we have found that the
majority of patients are interested in mobile apps for outpa-
tient management of hydrocephalus. In response to our sur-
vey, we have developed Hydroapp with support of patients
volunteer and foucusing on the patients expectations as per
table 2. We will follow this up with a feasibility study of the
custom designed Hydroapp.
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